Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Biol Ther. 2006 Aug;6(8):807-21.

Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL and ADACEL.

Author information

1
Dalhousie University, Canadian Centre for Vaccinology, Departments of Pediatrics and Microbiology & Immunology, IWK Health Centre, 5850/5980 University Avenue, Halifax, Nova Scotia, B3K 6R8, Canada. scott.halperin@dal.ca

Abstract

Acellular pertussis-containing combination vaccines are widely used in the developed world for the control of pertussis and have been successful in controlling disease in preschool-aged children. Combination vaccines formulated for use in adolescents and adults have been developed more recently and are increasingly being implemented for the control of pertussis in these age groups. One such family of products is PENTACEL (Haemophilus influenzae type b conjugate vaccine reconstituted with component pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine, DTaP-IPV-Hib), for use in young children, and ADACEL (tetanus and diphtheria toxoids adsorbed combined with component pertussis vaccine, dTap) for use in adolescents and adults. These products have been demonstrated to be safe, immunogenic and effective for the control of pertussis and the other included diseases.

PMID:
16856802
DOI:
10.1517/14712598.6.8.807
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center